New drug shows promise for blood cancer control in small japanese study
NCT ID NCT05673460
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 26 times
Summary
This early-phase study tested the safety and tolerability of a new drug called nemtabrutinib in 7 Japanese adults with certain blood cancers (like chronic lymphocytic leukemia). The goal was to see how the body handles the drug and if it can help control the disease. Because patients may need ongoing treatment, this is considered disease control, not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MATURE B-CELL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chiba Cancer Center ( Site 0005)
Chiba, 260-8717, Japan
-
Kindai University Hospital ( Site 0006)
Sayama, Osaka, 589-8511, Japan
-
Kyushu University Hospital ( Site 0008)
Fukuoka, 812-8582, Japan
-
Nagoya University Hospital ( Site 0003)
Nagoya, Aichi-ken, 466-8560, Japan
-
National Cancer Center Hospital East ( Site 0002)
Kashiwa, Chiba, 2778577, Japan
-
Okayama University Hospital ( Site 0007)
Okayama, 700-8558, Japan
-
Yamagata University Hospital ( Site 0001)
Yamagata, 990-9585, Japan
Conditions
Explore the condition pages connected to this study.